TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

Shares of Cronos Group Inc. CRON shed 1.55% to $1.90 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.18% to 17,436 ...

How Do Unusual Items Influence Profit? For anyone who wants to understand Cronos Group's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory ...

Tower Research Capital LLC TRC boosted its stake in shares of Cronos Group by 140.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company’s stock valued ...

Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 ...

Good morning. My name is Antoine, and I will be your conference operator today. I would like to welcome everyone to Cronos Group's fourth-quarter and full-year 2024 earnings conference call. Today's ...

Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany with a market cap of CA$1.13 billion.

My name is Antoine, and I will be your conference operator today. I would like to welcome everyone to Cronos Group's fourth-quarter and full-year 2024 earnings conference call. Today's call is ...